文献速递泌尿生殖腹部MR

自动深度影像组学框架用于血清前列腺特异性抗原4.0-10.0 ng/mL患者的前列腺癌诊断与分层:一项多中心回顾性研究

An Automatic Deep-Radiomics Framework for Prostate Cancer Diagnosis and Stratification in Patients with Serum Prostate-Specific Antigen of 4.0-10.0 ng/mL: A Multicenter Retrospective Study.
PubMed 文献 · Acad Radiol · 2025-01-02

研究纳入1124例组织学结果完整且PSA 4-10 ng/mL的患者,基于双参数MRI构建自动深度影像组学框架(nnUNet分割前列腺、提取可疑病灶特征),联合影像组学与临床特征诊断前列腺癌、临床显著前列腺癌和高危临床显著前列腺癌,内部测试AUC分别为0.80、0.88、0.83,外部测试AUC分别为0.79、0.80、0.82,外部队列中优于PSAD、F/T PSA和PI-RADS评分。

要点

  • 联合影像组学与临床特征的模型优于单用影像组学或临床特征。
  • 外部测试诊断前列腺癌、临床显著前列腺癌、高危临床显著前列腺癌AUC为0.79、0.80、0.82。
  • 外部队列中深度影像组学模型优于PSAD、F/T PSA和PI-RADS评分。

核心结论

  • 深度影像组学模型可自动分割前列腺和可疑病灶,对PSA 4-10 ng/mL患者完成前列腺癌诊断与分层,提供多层次预测以辅助临床决策。

研究设计与样本

  • 多中心回顾性研究,纳入1124例有组织学结果且PSA 4-10 ng/mL的患者,数据来自一个公共数据集和两个本地机构;训练nnUNet分割前列腺,特征提取模块识别可疑病灶,基于双参数MRI提取影像组学特征,构建机器学习模型并在内部和外部队列评估。

诊断标准与关键数值

  • 联合影像组学与临床特征的模型在内部测试诊断前列腺癌、临床显著前列腺癌、高危临床显著前列腺癌的AUC分别为0.80、0.88、0.83,外部测试分别为0.79、0.80、0.82。

临床应用与阅片要点

  • 外部队列中该深度影像组学模型优于PSAD、F/T PSA和PI-RADS评分,决策曲线分析显示其净获益大于这些方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop an automatic deep-radiomics framework that diagnoses and stratifies prostate cancer in patients with prostate-specific antigen (PSA) levels between 4 and 10 ng/mL.

MATERIALS AND METHODS: A total of 1124 patients with histological results and PSA levels between 4 and 10 ng/mL were enrolled from one public dataset and two local institutions. An nnUNet was trained for prostate masks, and a feature extraction module identified suspicious lesion masks. Radiomics features were extracted from the biparametric magnetic resonance imaging using these masks. Machine learning models were developed to diagnose prostate cancer (PCa), clinically significant PCa (csPCa), and high-risk csPCa based on radiomics and clinical features. The models were evaluated in both internal and external cohorts. The best model was further compared with PSA density (PSAD), free to total PSA (F/T PSA), and Prostate Imaging Reporting and Data System (PI-RADS) scores in the external cohort.

RESULTS: The models based on both radiomics and clinical features outperformed those based on radiomics or clinical features alone. The top-performing models achieved areas under the curve of 0.80, 0.88, and 0.83 on internal testing, and 0.79, 0.80, and 0.82 on external testing for diagnosing PCa, csPCa, and high-risk csPCa. Our deep-radiomics model surpassed PSAD, F/T PSA, and PI-RADS scores in an external cohort. Decision curve analysis indicated that our model offers greater net benefit than these methods.

CONCLUSION: The deep-radiomics model automatically segments prostate and suspicious lesions, diagnoses, and stages of PCa in patients with PSA levels between 4 and 10 ng/mL. Our method addresses the shortcomings of manual segmentation and inconsistency, delivering outstanding performance. It provides multilevel predictions to assist clinical decision-making and benefit patients with gray zone PSA.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zheng B, Mo F, Shi X, et al. An Automatic Deep-Radiomics Framework for Prostate Cancer Diagnosis and Stratification in Patients with Serum Prostate-Specific Antigen of 4.0-10.0 ng/mL: A Multicenter Retrospective Study. Acad Radiol. 2025. PMID: 39753478. doi:10.1016/j.acra.2024.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。